Nov-20
Oct-20
Endocrinology Neurology Pharmacoepidemiology
Read moreOct-20
Endocrinology Neurology Pharmacoepidemiology
Read moreOct-20
Cardiovascular Neurology Pharmacoepidemiology
Read moreOct-20
Mental Health Pharmacoepidemiology
Read moreOct-20
Dermatology Endocrinology Gynecology and Obstetrics Pharmacoepidemiology Women's Health
Read moreOct-20
Mental Health Neurology Pharmacoepidemiology
Read moreOct-20
Pharmacoepidemiology Rheumatology
Read moreOct-20
Pharmacoepidemiology Rheumatology
Read moreOct-20
Pharmacoepidemiology Phlebology
Read moreOct-20
Musculoskeletal Pharmacoepidemiology Rheumatology
Read moreOct-20
Gynecology and Obstetrics Pharmacoepidemiology Women's Health
Read moreDate | Title | Categories | |
---|---|---|---|
Nov-20 | Rationale and design of a European epidemiological post-authorization safety study (PASS) program: rivaroxaban use in routine clinical practice | Read more | |
Oct-20 | Diabetes medications and risk of Parkinson’s disease: a cohort study of patients with diabetes | Read more | |
Oct-20 | Differential risk of Parkinsons disease according to diabetes treatments: A cohort study | Read more | |
Oct-20 | Impact Of Multiple Cardiovascular Medications On Mortality After An Incidence Of Ischaemic Stroke Or Transient Ischaemic Attack: a 10-year Cohort Study | Read more | |
Oct-20 | Incidence Of Anorexia Nervosa And The Prescribing Of Psychotropic Medications From Uk Primary Care, 1996-2016: A Retrospective Database Study | Read more | |
Oct-20 | Reduction in Use of cyproterone/ethinylestradiol (Diane-35 and Generics) After Risk Minimization Measures in the Netherlands, UK and Italy |
Dermatology Endocrinology Gynecology and Obstetrics Pharmacoepidemiology Women's Health |
Read more |
Oct-20 | Risk of seizure in people with autism spectrum disorder using antipsychotic medication: A population based study | Read more | |
Oct-20 | Secular trends in first line treatment with disease modifying antirheumatic drugs in rheumatoid arthritis: An international real‐world study by the OHDSI and EHDEN networks | Read more | |
Oct-20 | Sodium-Glucose Co-Transporter-2 Inhibitors and the Risk for Gout – a Comparison Among Canagliflozin, Dapagliflozin and Empagliflozin | Read more | |
Oct-20 | Validation Of Venous Thromboembolism Diagnoses In Patients Receiving Rivaroxaban Or Warfarin In The Health Improvement Network Database Of Primary Care Electronic Health Records In The United Kingdom | Read more | |
Oct-20 | Warfarin Use and Risk of Knee and Hip Replacements | Read more | |
Oct-20 | What Medications Are Prescribed To Women During Their Postnatal Check? |
Gynecology and Obstetrics Pharmacoepidemiology Women's Health |
Read more |